NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ![]() Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. | |
Founding Date | Founding Date 2006 | Founding Date 2006 | Founding Date 1996 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Emeryville, US HQ Maidenhead, GB | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB |
Employees | Employees 91 | Employees 743% increase | Employees 37 |
Financial | |||
Revenue (est.) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $230.1m (FY, 2016) |
Cost of goods | Cost of goods £11.1m (FY, 2025) | Cost of goods $4.8m (FY, 2021) | Cost of goods $76m (FY, 2016) |
Gross profit | Gross profit £38.2m (FY, 2025) | Gross profit N/A | Gross profit $154.1m (FY, 2016) |
Net income | Net income £7m (FY, 2025) | Net income ($227.4m) (FY, 2021) | Net income $18.5m (FY, 2016) |

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
View company